Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jonas Nelson

Plastic and Reconstructive Surgery New York, NY Medical Doctor

NPI 1083932073 CMS profile 139642

1275 York Ave, New York, NY 10065

Open in the dashboard

General payments

$7,816

98 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jonas Nelson of New York, NY is reported in the CMS Open Payments database as having received $7,816 across 98 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,138 29
2024 General $1,501 35
2023 General $3,997 22
2022 General $559 7
2020 General $50 3
2019 General $572 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonas Nelson
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Jonas Nelson were reported at $1,138. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Jonas Nelson Plastic and Reconstructive Surgery median Middle half National median
2019 $572 $335 $121–$1,264 $163
2020 $50 $162 $57–$417 $114
2021 $0 $245 $89–$735 $132
2022 $559 $325 $120–$932 $149
2023 $3,997 $343 $129–$999 $160
2024 $1,501 $390 $141–$1,085 $164
2025 $1,138 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. RTI Surgical, Inc $3,314 5 payments
  2. AbbVie, Inc. $2,159 69 payments
  3. Sientra, Inc. $767 4 payments
  4. Allergan Inc. $316 4 payments
  5. Kerecis Limited $257 2 payments
  6. Davol Inc. $235 3 payments
  7. DePuy Synthes Sales Inc. $196 3 payments
  8. TELA Bio, Inc. $193 2 payments
  9. AxoGen $161 1 payment
  10. Integra LifeSciences Corporation $89 1 payment
  11. Other $129 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,778 95 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,000 1 payment
  3. Education $39 2 payments
Products named General payments · program years 2019–2025
  1. CORTIVA ALLOGRAFT DERMIS $3,314 5 payments
  2. ALLODERM $2,101 65 payments
  3. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $767 4 payments
  4. ARISTA AH FlexiTip $197 1 payment
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $194 5 payments
  6. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $193 2 payments
  7. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $180 3 payments
  8. Avance Nerve Graft $161 1 payment
  9. Kerecis SurgiClose Wound Care $150 1 payment
  10. Kerecis SurgiClose Wound Care $150 1 payment
  11. Other $1,657 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$96,481

Medicare's payments for the services billed

Medicare patients

157

Average age 71

Services billed

330

119 women, 38 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Cancer 75%
High blood pressure 68%
Arthritis 50%
Diabetes 28%
Osteoporosis 27%
Ischemic heart disease 24%
Depression 22%
Chronic kidney disease 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

98 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record